652
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluations

Pharmacokinetic evaluation of fluconazole in critically ill patients

, B Pharm Hons, , BMBS PhD, , PhD, , , MD & , PhD
Pages 1431-1440 | Published online: 02 Sep 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Nynke G. L. Jager, Reinier M. van Hest, Jeffrey Lipman, Fabio S. Taccone & Jason A. Roberts. (2016) Therapeutic drug monitoring of anti-infective agents in critically ill patients. Expert Review of Clinical Pharmacology 9:7, pages 961-979.
Read now

Articles from other publishers (12)

Emmanuel Novy, Claire Roger, Jason A. Roberts & Menino Osbert Cotta. (2023) Pharmacokinetic and pharmacodynamic considerations for antifungal therapy optimisation in the treatment of intra-abdominal candidiasis. Critical Care 27:1.
Crossref
Maggie M. Chau, Kathryn Daveson, Jan‐Willem C. Alffenaar, Amanda Gwee, Su Ann Ho, Deborah J. E. Marriott, Jason A. Trubiano, Jessie Zhao, Jason A. Roberts, Monica A. Slavin, Karin A. Thursky, Jason A. Roberts, Leon J. Worth, Christina C. Chang, Sharon C‐A Chen, C. Orla Morrissey, Christopher C. Blyth & Anna Khanina. (2021) Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy and haemopoietic stem cell transplant recipients, 2021. Internal Medicine Journal 51:S7, pages 37-66.
Crossref
Fekade B. Sime & Jason A. Roberts. 2018. Abdominal Sepsis. Abdominal Sepsis 319 342 .
M. Fernández-Ruiz, J. Guinea, D. Lora-Pablos, Ó. Zaragoza, M. Puig-Asensio, B. Almirante, M. Cuenca-Estrella, J.M. Aguado, B. Padilla, P. Muñoz, J. Guinea, J.R. Paño Pardo, J. García-Rodríguez, C.G. Cerrada, J. Fortún, P. Martín, E. Gómez, P. Ryan, C. Campelo, I. de los Santos Gil, V. Buendía, B.P. Gorricho, M. Alonso, F.S. Sanz, J.M. Aguado, P. Merino, F. González Romo, M. Gorgolas, I. Gadea, J.E. Losa, A. Delgado-Iribarren, A. Ramos, Y. Romero, I.S. Romero, O. Zaragoza, M. Cuenca-Estrella, J. Rodríguez-Baño, A.I. Suarez, A. Loza, A.I. Aller García, E. Martín-Mazuelos, M.R. Pérez de Pipaón, J. Garnacho, C. Ortiz, M. Chávez, F.L. Maroto, M. Salavert, J. Pemán, J. Blanquer, D. Navarro, J.J. Camarena, R. Zaragoza, V. Abril, C. Gimeno, S. Hernández, G. Ezpeleta, E. Bereciartua, J.L. Hernández Almaraz, M. Montejo, R.A. Rivas, R. Ayarza, A.M. Planes, I.R. Camps, B. Almirante, J. Mensa, M. Almela, M. Gurgui, F. Sánchez-Reus, J. Martínez-Montauti, M. Sierra, J.P. Horcajada, L. Sorli, J. Gómez, A. Gené, M. Urrea, A. Mularoni, M. Valerio, A. Díaz-Martín & F. Puchades. (2017) Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance. Clinical Microbiology and Infection 23:9, pages 672.e1-672.e11.
Crossref
H. Hof. (2016) Candidurie! Was nun?Candiduria! What now?. Der Urologe 56:2, pages 172-179.
Crossref
Mahipal G. Sinnollareddy, Michael S. Roberts, Jeffrey Lipman, Melissa Lassig-Smith, Therese Starr, Thomas Robertson, Sandra L. Peake & Jason A. Roberts. (2016) In Vivo Microdialysis To Determine Subcutaneous Interstitial Fluid Penetration and Pharmacokinetics of Fluconazole in Intensive Care Unit Patients with Sepsis . Antimicrobial Agents and Chemotherapy 60:2, pages 827-832.
Crossref
Nicolette R. Holt & Karin A. Thursky. 2016. Drug Dosing in Obesity. Drug Dosing in Obesity 77 96 .
T. Brosh-Nissimov & R. Ben-Ami. (2015) Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection. Clinical Microbiology and Infection 21:11, pages 1011-1017.
Crossref
Andrew A Udy, Paul Jarrett, Janine Stuart, Melissa Lassig-Smith, Therese Starr, Rachel Dunlop, Steven C Wallis, Jason A Roberts & Jeffrey Lipman. (2014) Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds. Critical Care 18:6.
Crossref
George Dimopoulos, Anastasia Antonopoulou, Apostolos Armaganidis & Jean-Louis Vincent,. (2013) How to select an antifungal agent in critically ill patients. Journal of Critical Care 28:5, pages 717-727.
Crossref
Pierre Charbonneau & Michel WolffJ.-F. Timsit, L. Potton, M. Lugosi, C. Minet, R. Hamidfar-Roy, C. Ara-Somohano, A. Bonadona & C. Schwebel. 2013. Infectiologie en réanimation. Infectiologie en réanimation 105 120 .
Jason A Roberts, Jan J De Waele, George Dimopoulos, Despoina Koulenti, Claude Martin, Philippe Montravers, Jordi Rello, Andrew Rhodes, Therese Starr, Steven C Wallis & Jeffrey Lipman. (2012) DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic. BMC Infectious Diseases 12:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.